Cargando…

Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma

Liver cancer has high rates of morbidity and mortality, and its treatment is a global health challenge. Hepatocellular carcinoma (HCC) accounts for 90% of all primary liver cancer cases. B-lymphoma Mo-MLV insertion region 1 (BMI1) has been identified as a proto-oncogene, which contributes to the ini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ru, Fan, Hengwei, Sun, Ming, Lv, Zhongwei, Yi, Wanwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793120/ https://www.ncbi.nlm.nih.gov/pubmed/35072573 http://dx.doi.org/10.1177/15330338211070689

Ejemplares similares

The regulation role and diagnostic value of fibrinogen-like protein 1 revealed by pan-cancer analysis
por: Yi, Wanwan, et al.
Publicado: (2022)

Effect of umifenovir (arbidol) versus standard care on clinical outcome in patients with COVID-19: a retrospective cohort study
por: Yi, Wanwan, et al.
Publicado: (2023)

An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer
por: Yi, Wanwan, et al.
Publicado: (2020)

Weighted Gene Coexpression Network Analysis Reveals the Dynamic Transcriptome Regulation and Prognostic Biomarkers of Hepatocellular Carcinoma
por: Qu, Shuping, et al.
Publicado: (2020)

Clinical implications of different specimen types for nucleic acid testing in two cases of COVID-19
por: Fan, Hengwei, et al.
Publicado: (2020)

The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma
por: Khan, Suliman, et al.
Publicado: (2022)

A Pretreatment CT Model Predicts Survival Following Chemolipiodolization in Patients With Hepatocellular Carcinoma
por: Zhang, Yijun, et al.
Publicado: (2019)

Risk factors for recurrent positive results of the nucleic acid amplification test for COVID-19 patients: a retrospective study
por: Yi, Wanwan, et al.
Publicado: (2021)

Validation of Bmi1 as a Therapeutic Target of Hepatocellular Carcinoma in Mice
por: Qi, Shibo, et al.
Publicado: (2014)

Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1
por: Wu, Wen-rui, et al.
Publicado: (2016)

Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression (Review)
por: Chen, Yi-Li, et al.
Publicado: (2023)

Alantolactone inhibits cervical cancer progression by downregulating BMI1
por: Sun, Xiaodong, et al.
Publicado: (2021)

Long noncoding RNAs in the initiation, progression, and metastasis of hepatocellular carcinoma
por: DiStefano, Johanna K.
Publicado: (2017)

Negative regulation of Bmi-1 by AMPK and implication in cancer progression
por: Huang, Deqiang, et al.
Publicado: (2015)

The clinicopathological significance and prognostic value of EMMPRIN overexpression in cancers: evidence from 39 cohort studies
por: Fan, Hengwei, et al.
Publicado: (2017)

The role of APE/Ref-1 signaling pathway in hepatocellular carcinoma progression
por: YANG, ZHEN, et al.
Publicado: (2014)

Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy
por: Yin, Zeli, et al.
Publicado: (2018)

Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2016)

CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity
por: Dong, Zhao-Ru, et al.
Publicado: (2021)

The Oncogenic Role of ARG1 in Progression and Metastasis of Hepatocellular Carcinoma
por: You, Jia, et al.
Publicado: (2018)

The Suppressive Role and Aberrent Promoter Methylation of BTG3 in the Progression of Hepatocellular Carcinoma
por: Lv, Zhenbing, et al.
Publicado: (2013)

Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma
por: Akkız, Hikmet
Publicado: (2023)

Targeting Ca(2+) Signaling in the Initiation, Promotion and Progression of Hepatocellular Carcinoma
por: Ali, Eunus S., et al.
Publicado: (2020)

Cyr61/CCN1 Is Regulated by Wnt/β-Catenin Signaling and Plays an Important Role in the Progression of Hepatocellular Carcinoma
por: Li, Zhi-Qiang, et al.
Publicado: (2012)

The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis
por: Zhai, Run, et al.
Publicado: (2016)

LncRNA-SNHG6 promotes the progression of hepatocellular carcinoma by targeting miR-6509-5p and HIF1A
por: Fan, Xiaoxi, et al.
Publicado: (2021)

Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma
por: Cao, Zhongwei, et al.
Publicado: (2014)

Outcome of Initial Progression During Nivolumab Treatment for Hepatocellular Carcinoma: Should We Use iRECIST?
por: Lee, Dong Ho, et al.
Publicado: (2021)

Role of PRKDC in cancer initiation, progression, and treatment
por: Chen, Yu, et al.
Publicado: (2021)

Corrigendum to “The Oncogenic Role of ARG1 in Progression and Metastasis of Hepatocellular Carcinoma”
por: You, Jia, et al.
Publicado: (2019)

Association of gastrointestinal symptoms and skipping breakfast with anxiety and depressive symptoms in quarantined Chinese college students during the Shanghai 2022 lockdown: a cross sectional survey
por: Qiao, Tingting, et al.
Publicado: (2023)

The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma
por: Lee, Yi-Te, et al.
Publicado: (2021)

The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma
por: Yang, Naibin, et al.
Publicado: (2016)

The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma
por: Jiang, Han-yu, et al.
Publicado: (2022)

Cathepsin-facilitated invasion of BMI1-high hepatocellular carcinoma cells drives bile duct tumor thrombi formation
por: Xu, Lei-Bo, et al.
Publicado: (2023)

The role of DEK protein in hepatocellular carcinoma for progression and prognosis
por: Lin, Li-juan, et al.
Publicado: (2013)

Role of nonresolving inflammation in hepatocellular carcinoma development and progression
por: Yu, Le-Xing, et al.
Publicado: (2018)

Role of insulin receptor substrates in the progression of hepatocellular carcinoma
por: Sakurai, Yoshitaka, et al.
Publicado: (2017)

Recent progress in the emerging role of exosome in hepatocellular carcinoma
por: Abudoureyimu, Mubalake, et al.
Publicado: (2018)

Roles of Extracellular Vesicles on the Progression and Metastasis of Hepatocellular Carcinoma
por: Seay, Turner W., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8asa360vndr3pkqgqvla0evbsp